Merck wrote drug studies for doctors
New York Times, April 17, 2008
Drug maker Merck drafted dozens of research studies for a best-selling drug, then lined up prestigious doctors to put their names on the reports before publication, according to a report. The report provides a look in the industry practice of ghostwriting medical research studies that are then published in academic journals. The authors of the study say it raises broad questions about the validity of much of the drug industry's published research, because the ghostwriting practice appears to be widespread.
- Providers Lag as Consumers Set Agenda
- ICD-10 Delay Alters Provider, Vendor Prep
- Esther Dyson Launches Population Health Challenge
- Crisis Spurs Healthcare Payment Reform in Arkansas
- Payment Reform Naysayers 'Better Wake Up'
- Look Beyond Nurse-Patient Ratios
- HIT Leaders Want Flexibility, Transparency from Next HHS Chief
- Reduce Readmissions by Activating Patients to Do 'Self-Care'
- As Hospitalist Patient Loads Rise, So Do Hospital Costs
- Hospital Groups Back NQF Report on Patient Sociodemographics